Medicine and Dentistry
Analgesia
11%
Antibiotic Resistance
11%
Apoplexy
11%
Biological Product
13%
Chromosome Deletion 22q11
11%
Chronic Pancreatitis
11%
Cohort Effect
11%
Colitis
15%
Combination Therapy
18%
Cooperation
18%
Crohn's Disease
68%
Diagnosis
23%
Diagnostic Test
11%
Disease
41%
Disease Course
35%
Drug Therapy
18%
Enteropathy
16%
Erythrodermic Psoriasis
11%
Gastrointestinal Bleeding
11%
Gastrointestinal Disease
11%
General Practitioner
11%
Helicobacter Pylori
11%
Hepatitis E Virus
11%
Immunosuppressant
11%
Immunosuppressive Drug
14%
Immunosuppressive Treatment
28%
Inflammatory Bowel Disease
100%
Inflammatory Bowel Disease
22%
Infliximab
11%
Irritable Bowel Syndrome
11%
Jejunum Ulcer
11%
Keyhole Limpet Hemocyanin
11%
Life Cycle
11%
Mercaptopurine
11%
Methotrexate
11%
Network Meta-Analysis
11%
Nodular Regenerative Hyperplasia
11%
Patient with Crohn's Disease
20%
Patient with Inflammatory Bowel Disease
30%
Patient with Ulcerative Colitis
15%
Pediatric Gastroenterology
22%
Pediatric Nutrition
22%
Polysaccharide
11%
Randomized Controlled Trial
15%
Rheumatology
11%
Systematic Review
11%
Tumor Necrosis Factor
11%
Ulcerative Colitis
48%
Vedolizumab
11%
Water-Electrolyte Imbalance
11%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Abscess
11%
Acalculous Cholecystitis
11%
Aminosalicylic Acid
9%
Biological Product
12%
Briakinumab
6%
Cerebrovascular Accident
11%
Chromosome Deletion 22q11
11%
Coeliac Disease
11%
Combination Therapy
14%
Crohn's Disease
80%
Disease
11%
Disease Activity
5%
Disease Severity
11%
Enteropathy
11%
Erythrodermic Psoriasis
11%
Gastrointestinal Disease
11%
Hypoparathyroidism
7%
Immunosuppressive Agent
18%
Inflammation
6%
Inflammatory Bowel Disease
77%
Infliximab
22%
Mercaptopurine
11%
Metabolic Disorder
11%
Methotrexate
11%
Pharmacotherapy
11%
Placebo
10%
Purpura
11%
Randomized Controlled Trial
12%
Recurrent Disease
11%
Remission
20%
Site-Directed Mutagenesis
11%
Tumor Necrosis Factor
12%
Ulcerative Colitis
56%
Ustekinumab
11%
Keyphrases
Absolute Indication
5%
ADP-ribosyltransferase
11%
Anti-IL-12
11%
Anti-tumor Necrosis Factor-α Agents
11%
Antigen-specific Immune Response
11%
Atypical Carcinoid
11%
Autochthonous Cases
5%
Autochthonous Hepatitis E
11%
Bench to Bedside
11%
Briakinumab
6%
Catalytic Site
11%
Clinical Examination Test
5%
Clinical Laboratory Test
5%
Clostridium Botulinum C2 Toxin
11%
CMV Colitis
11%
Component Network Meta-analysis
11%
Diagnostic Test Accuracy
11%
Early Crohn's Disease
11%
EndoClot
11%
Erythrodermic Psoriasis
11%
Grading Method
5%
Guideline Method
5%
Guidlines
11%
H1N1 Vaccine
11%
History Taking
5%
Ileocolonoscopy
5%
Inflammatory Intestinal Disease
11%
Keyhole Limpet Hemocyanin
11%
Local Defect
5%
Long-term Relapse
11%
Lung Neoplasms
5%
Mucosal Healing
11%
Network Meta-analysis Protocol
11%
Nodular Regenerative Hyperplasia
11%
Oral Antigen
11%
Paediatric Gastroenterology
11%
Pain Etiology
5%
Pancreatic Panniculitis
11%
Pediatric nutrition
11%
Pulmonary Neuroendocrine Tumor
11%
Review Network
11%
Seasonal Flu
5%
Site-directed mutagenesis
11%
Typical Carcinoid
5%
Vaccination Recommendation
11%
Vedolizumab
11%
Web Portal
11%
